Platelet Rich Fibrin is one of 115 biologic programs targeting Platelet-rich Fibrin. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
56 competitors in ESS
Lexapro
Proamatine
Quviviq
Opdualag
Opdivo
Darzalex
Platelet Rich Fibrin
Decadron
Revlimid
Kyprolis
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details